BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36608667)

  • 1. CDT1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis.
    Ratnayeke N; Baris Y; Chung M; Yeeles JTP; Meyer T
    Mol Cell; 2023 Jan; 83(1):26-42.e13. PubMed ID: 36608667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of DNA Replication Licensing and Re-Replication by Cdt1.
    Zhang H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1.
    Leng F; Saxena L; Hoang N; Zhang C; Lee L; Li W; Gong X; Lu F; Sun H; Zhang H
    J Biol Chem; 2018 Dec; 293(49):18879-18889. PubMed ID: 30301766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDT1, a licensing factor that limits rereplication.
    Rona G; Pagano M
    Mol Cell; 2023 Jan; 83(1):1-3. PubMed ID: 36608666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic UV irradiation induces a DNA replication-licensing defect that potentiates G1 arrest response.
    Morino M; Nukina K; Sakaguchi H; Maeda T; Takahara M; Shiomi Y; Nishitani H
    PLoS One; 2015; 10(3):e0120553. PubMed ID: 25798850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential replication-coupled destruction at G1/S ensures genome stability.
    Coleman KE; Grant GD; Haggerty RA; Brantley K; Shibata E; Workman BD; Dutta A; Varma D; Purvis JE; Cook JG
    Genes Dev; 2015 Aug; 29(16):1734-46. PubMed ID: 26272819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.
    Shibata E; Abbas T; Huang X; Wohlschlegel JA; Dutta A
    Mol Cell Biol; 2011 Aug; 31(15):3136-45. PubMed ID: 21628527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-stimulated mitogen-activated protein kinases control the stability and activity of the Cdt1 DNA replication licensing factor.
    Chandrasekaran S; Tan TX; Hall JR; Cook JG
    Mol Cell Biol; 2011 Nov; 31(22):4405-16. PubMed ID: 21930785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation.
    Li X; Zhao Q; Liao R; Sun P; Wu X
    J Biol Chem; 2003 Aug; 278(33):30854-8. PubMed ID: 12840033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of conserved arginine residues on Cdt1 that affect licensing activity and interaction with Geminin or Mcm complex.
    You Z; Ode KL; Shindo M; Takisawa H; Masai H
    Cell Cycle; 2016 May; 15(9):1213-26. PubMed ID: 26940553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Licensing Factor Cdt1 Links Cell Cycle Progression to the DNA Damage Response.
    Kanellou A; Giakoumakis NN; Panagopoulos A; Tsaniras SC; Lygerou Z
    Anticancer Res; 2020 May; 40(5):2449-2456. PubMed ID: 32366388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCAF14 regulates CDT2 to promote SET8-dependent replication fork protection.
    Tirado-Class N; Hathaway C; Nelligan A; Nguyen T; Dungrawala H
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37940188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.
    Kim Y; Starostina NG; Kipreos ET
    Genes Dev; 2008 Sep; 22(18):2507-19. PubMed ID: 18794348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase.
    Clijsters L; Wolthuis R
    J Cell Sci; 2014 Mar; 127(Pt 6):1336-45. PubMed ID: 24434580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct and sequential re-replication barriers ensure precise genome duplication.
    Zhou Y; Pozo PN; Oh S; Stone HM; Cook JG
    PLoS Genet; 2020 Aug; 16(8):e1008988. PubMed ID: 32841231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A spontaneous Cdt1 mutation in 129 mouse strains reveals a regulatory domain restraining replication licensing.
    Coulombe P; Grégoire D; Tsanov N; Méchali M
    Nat Commun; 2013; 4():2065. PubMed ID: 23817338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Checkpoint kinase ATR phosphorylates Cdt2, a substrate receptor of CRL4 ubiquitin ligase, and promotes the degradation of Cdt1 following UV irradiation.
    Sakaguchi H; Takami T; Yasutani Y; Maeda T; Morino M; Ishii T; Shiomi Y; Nishitani H
    PLoS One; 2012; 7(9):e46480. PubMed ID: 23029527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis of DNA replication licensing factor Cdt1 in S-phase is performed independently of geminin through its N-terminal region.
    Nishitani H; Lygerou Z; Nishimoto T
    J Biol Chem; 2004 Jul; 279(29):30807-16. PubMed ID: 15138268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.
    Rizzardi LF; Coleman KE; Varma D; Matson JP; Oh S; Cook JG
    J Biol Chem; 2015 Jan; 290(1):556-67. PubMed ID: 25411249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the p12 subunit of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells.
    Zhao H; Zhang S; Xu D; Lee MY; Zhang Z; Lee EY; Darzynkiewicz Z
    Cell Cycle; 2014; 13(22):3529-40. PubMed ID: 25483089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.